Denali Therapeutics
DNLI
#4389
Rank
HK$13.29 B
Marketcap
HK$91.58
Share price
-7.90%
Change (1 day)
-39.60%
Change (1 year)

Denali Therapeutics (DNLI) - P/B ratio

P/B ratio as of April 2025 : 1.41

According to Denali Therapeutics 's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Denali Therapeutics - P/B ratio (from 2017 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.41-16.15%
2023-12-312.88-20.61%
2022-12-313.62-35.99%
2021-12-315.66-35.16%
2020-12-318.73105.74%
2019-12-314.2418.65%
2018-12-313.5821.07%
2017-12-312.95
2016-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
4.97 252.35% Jersey
-1.55-209.71%๐Ÿ‡บ๐Ÿ‡ธ USA
9.94 604.93%๐Ÿ‡บ๐Ÿ‡ธ USA
4.74 235.89%๐Ÿ‡ฌ๐Ÿ‡ง UK